chlorzoxazone has been researched along with Nasopharyngeal Neoplasms in 1 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hou, DF | 1 |
Wang, SL | 1 |
He, ZM | 1 |
Yang, F | 1 |
Chen, ZC | 1 |
1 other study available for chlorzoxazone and Nasopharyngeal Neoplasms
Article | Year |
---|---|
Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro.
Topics: Animals; Biopsy; Cell Death; Cells, Cultured; Chlorzoxazone; Cytochrome P-450 CYP2E1; Dose-Response | 2007 |